[1]
2018. BCL-2 TARGETED STRUCTURAL BASED COMPUTER AIDED DRUG DESIGN (CAAD) FOR THERAPEUTIC ASSESSMENT OF RICIN IN PROSTATE CANCER. International Journal of Pharmaceutical Sciences and Drug Research. 7, 2 (Sep. 2018), 168–171. DOI:https://doi.org/10.25004/IJPSDR.2015.070207.